Oneness Biotech Co

Oneness Biotech Co FCF per Share

The Free Cash Flow per Share of Oneness Biotech Co (4743.TWO) as of Oct 31, 2026 is -1.02 TWD. In the previous year, Free Cash Flow per Share was -0.79 TWD — a change of 27.84% (lower).

FCF per Share

-1.02TWD

YoY

27.84%

Last updated:

Free Cash Flow per Share of Oneness Biotech Co is 2025 -1.02 TWD. Free Cash Flow per Share of Oneness Biotech Co was 2024 -0.79 TWD. It decreases by 27.84% lower compared to the previous year.

The Oneness Biotech Co FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.89 TWD
Jan 1, 2019
-0.98 TWD
Jan 1, 2020
0.01 TWD
Jan 1, 2021
-1.02 TWD
Jan 1, 2022
-2.19 TWD
Jan 1, 2023
-1.02 TWD
Jan 1, 2024
-0.79 TWD
Jan 1, 2025
-1.02 TWD
The Oneness Biotech Co FCF per Share history
YEARFCF per ShareYoY
-1.02TWD+27.84%
-0.79TWD-22.15%
-1.02TWD-53.31%
-2.19TWD+114.70%
-1.02TWD-7,998.62%
0.01TWD-101.31%
-0.98TWD+11.04%
-0.89TWD-64.43%
-2.49TWD+88.21%
-1.32TWD+20.63%
-1.10TWD+20.79%
-0.91TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Oneness Biotech Co Stock analysis

What does Oneness Biotech Co do? Oneness Biotech Co., Ltd. generates revenue through the research and development of new drugs and the sale of pharmaceutical products and health products. The company focuses on health supplies, health food, and healthy food as its main products, which are distributed domestically. It also develops new drugs for treating chronic diabetic foot ulcers and anticancer drugs, targeting the domestic market for both its existing and new product lines. The firm's primary customers are domestic consumers seeking health and pharmaceutical solutions, including those requiring wound healing treatments for diabetic foot ulcers and anticancer therapies. Its product portfolio includes health supplies, health food, healthy food, and specialized drug developments, all sold within Taiwan's domestic market. Oneness Biotech's business model centers on developing and selling health and pharmaceutical products, with a particular emphasis on niche medical applications like diabetic foot ulcer treatments and cancer drugs. The company leverages its domestic distribution network to reach consumers interested in health-focused solutions and specialized medical treatments. Oneness Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oneness Biotech Co stock

Free Cash Flow per Share of Oneness Biotech Co is -1.02 TWD in 2025.

Free Cash Flow per Share of Oneness Biotech Co changed from -0.79 TWD to -1.02 TWD, representing a 27.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Oneness Biotech Co since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Oneness Biotech Co

All Key Metrics — Oneness Biotech Co